Vanguard Capital Management’s Allarity Therapeutics ALLR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$180K Hold
171,795
– – ﹤0.01% 3796
2026
Q2
$222K Hold
171,795
– – ﹤0.01% 3811
2026
Q1
$187K Buy
+171,795
New +$185K ﹤0.01% 3808

Other funds holding ALLR

Vanguard Capital Management's ALLR Position: Q3 2026 in Review

Vanguard Capital Management held its Allarity Therapeutics (ALLR) position steady in Q3 2026 at 171,795 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #3796.

Vanguard Capital Management first reported a position in ALLR in Q1 2026 and has held it in 3 quarters since. The position peaked at $222K in Q2 2026. 20 funds tracked by Wall St. Rank hold ALLR as of Q3 2026.

  • Vanguard Capital Management held 171,795 shares of Allarity Therapeutics worth $180K as of Q3 2026.
  • Vanguard Capital Management left its Allarity Therapeutics share count unchanged in Q3 2026.
  • Allarity Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3796 holding.
  • Vanguard Capital Management first reported a position in Allarity Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Allarity Therapeutics position peaked at $222K in Q2 2026.
  • 20 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.